Aditya Vision Limited has officially confirmed the dispatch of a Postal Ballot Notice to its shareholders, as announced on November 13, 2025. This communication follows the requirements set forth by the Securities and Exchange Board of India (SEBI) under the Listing Obligations and Disclosure Requirements regulations. The notice was published in two major newspapers: Business Standard (in English) and Aj (in Hindi). Shareholders can access further details via the company's website, www.adityavision.in, ensuring transparency and compliance with statutory obligations.

In addition to the postal ballot announcement, the company recently held a board meeting on November 12, 2025, where it reviewed and approved its standalone financial results for the quarter and six months ended September 30, 2025. The results have undergone a limited review by statutory auditors, who expressed an unmodified opinion in their report. Key financial figures reflected a significant increase in total income from operations, reaching ₹1,334.08 lakhs for the half-year period, compared to ₹1,081.49 lakhs in the previous year.

Moreover, Aditya Vision Limited has made strides in expanding its business operations by acquiring the business undertaking of Aspira DNA Diagnostics Gujarat LLP for ₹13.00 lakhs. This acquisition, effective from June 30, 2025, aligns with the company’s focus on growth and consolidation within its only business segment, pathology services. As of September 30, 2025, the company has no subsidiaries or associates, which simplifies its financial reporting. The results for the current quarter include operations from the acquired LLP, indicating a strategic move towards enhancing its market presence and operational capacity.